These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2122713)

  • 1. Effect of fat-emulsion phospholipids on serum lipoprotein profile during 1 mo of cyclic total parenteral nutrition.
    Messing B; Peynet J; Poupon J; Pfeiffer A; Thuillier F; Chazouillères O; Legrand A
    Am J Clin Nutr; 1990 Dec; 52(6):1094-100. PubMed ID: 2122713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles.
    Hajri T; Férézou J; Lutton C
    Biochim Biophys Acta; 1990 Nov; 1047(2):121-30. PubMed ID: 2248969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased lipoprotein X causes hyperlipidemia during intravenous administration of 10% fat emulsion in man.
    Tashiro T; Mashima Y; Yamamori H; Horibe K; Nishizawa M; Sanada M; Okui K
    JPEN J Parenter Enteral Nutr; 1991; 15(5):546-50. PubMed ID: 1942468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of lipoprotein X and its relationship to plasma lipid profile during different types of parenteral nutrition.
    Rigaud D; Serog P; Legrand A; Cerf M; Apfelbaum M; Bonfils S
    JPEN J Parenter Enteral Nutr; 1984; 8(5):529-34. PubMed ID: 6436526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipid and plasma lipoprotein concentrations in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion.
    Haumont D; Deckelbaum RJ; Richelle M; Dahlan W; Coussaert E; Bihain BE; Carpentier YA
    J Pediatr; 1989 Nov; 115(5 Pt 1):787-93. PubMed ID: 2809914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma lipoproteins and total parenteral nutrition with intravenous fat emulsion.
    Judd RH; Freund H; Deckelbaum RJ
    JPEN J Parenter Enteral Nutr; 1984; 8(5):552-5. PubMed ID: 6436530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.
    Griffin E; Breckenridge WC; Kuksis A; Bryan MH; Angel A
    J Clin Invest; 1979 Dec; 64(6):1703-12. PubMed ID: 227938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a medium-chain triacylglycerol/long-chain triacylglycerol fat emulsion containing a reduced ratio of phospholipid to triacylglycerol in pediatric surgical patients.
    Lai HS; Lin WH; Wu HC; Chang KJ; Chen WJ
    Nutrition; 2005; 21(7-8):825-30. PubMed ID: 15975490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term parenteral nutrition with glucose and Intralipid: effects on serum lipids and lipoproteins.
    Weinberg RB; Singh KK
    Am J Clin Nutr; 1989 May; 49(5):794-8. PubMed ID: 2497630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of fat emulsion on serum lipids in postoperative patients.
    Meguid MM; Kurzer M; Hayashi RJ; Akahoshi MP
    JPEN J Parenter Enteral Nutr; 1989; 13(1):77-80. PubMed ID: 2494371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of lipoprotein profile during total parenteral nutrition with intralipid 10%.
    Tashiro T; Mashima Y; Yamamori H; Okui K
    JPEN J Parenter Enteral Nutr; 1986; 10(6):622-6. PubMed ID: 3099006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and metabolic tolerance of a concentrated long-chain triglyceride lipid emulsion in critically ill septic and trauma patients.
    García-de-Lorenzo A; López-Martínez J; Planas M; Chacón P; Montejo JC; Bonet A; Ortiz-Leyba C; Sánchez-Segura JM; Ordóñez J; Acosta J; Grau T; Jiménez FJ
    JPEN J Parenter Enteral Nutr; 2003; 27(3):208-15. PubMed ID: 12757115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous intralipid 10% vs. 20%, hyperlipidemia, and increase in lipoprotein X in humans.
    Tashiro T; Mashima Y; Yamamori H; Sanada M; Nishizawa M; Okui K
    Nutrition; 1992; 8(3):155-60. PubMed ID: 1525430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein pattern during long-term home parenteral nutrition with two lipid emulsions.
    Richelle M; Rubin M; Kulapongse S; Deckelbaum RJ; Elwyn DH; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1993; 17(5):432-7. PubMed ID: 8289409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of different fat emulsions with 10 or 20% MCT/LCT or LCT on lipoproteins in plasma of patients after abdominal surgery.
    Hailer S; Jauch KW; Wolfram G
    Ann Nutr Metab; 1998; 42(3):170-80. PubMed ID: 9657461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of liposomal content of lipid emulsions on plasma lipid concentrations in low birth weight infants receiving parenteral nutrition.
    Haumont D; Richelle M; Deckelbaum RJ; Coussaert E; Carpentier YA
    J Pediatr; 1992 Nov; 121(5 Pt 1):759-63. PubMed ID: 1432430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phospholipids as emulsifiers in fat emulsions--effect on phospholipids in the serum lipoprotein fraction d greater than 1.063].
    Hailer S; Kalb S; Wolfram G
    Z Ernahrungswiss; 1988 Mar; 27(1):23-9. PubMed ID: 3376501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of administration of different intravenous lipid emulsions on plasma LP-X concentrations in the rat.
    Tomsits E; Rischák K; Molnár M; Filiczky I; Szollár L
    JPEN J Parenter Enteral Nutr; 1995; 19(5):369-72. PubMed ID: 8577013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolism of lipoprotein-X induced by infusion of 10% fat emulsion.
    Abe M; Kawano M; Tashiro T; Yamamori H; Takagi K; Morishima Y; Shirai K; Saitou Y; Nakajima N
    Nutrition; 1997 May; 13(5):417-21. PubMed ID: 9225333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial.
    Dellinger RP; Tomayko JF; Angus DC; Opal S; Cupo MA; McDermott S; Ducher A; Calandra T; Cohen J;
    Crit Care Med; 2009 Nov; 37(11):2929-38. PubMed ID: 19770753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.